Skip to main content
Top
Published in: BMC Cancer 1/2023

Open Access 01-12-2023 | Research

Completeness of regional cancer registry data in Northwest Russia 2008-2017

Authors: Anton Barchuk, Rustam Tursun-zade, Ekaterina Nazarova, Yuri Komarov, Ekaterina Tyurina, Yulia Tumanova, Alexey Belyaev, Ariana Znaor

Published in: BMC Cancer | Issue 1/2023

Login to get access

Abstract

Background

A national framework for population-based cancer registration was established in Russia in the late 1990s. Data comparability and validity analyses found substantial differences across ten population-based cancer registries (PBCRs)in Northwest Russia, and only four out of ten met international standards. This study aimed to assess the completeness of the PBCR data of those registries.

Methods

Qualitative and quantitative methods recommended for completeness and timeliness assessment were applied to the data from ten Russian regional PBCRs in Northwest Russia, covering a population of 13 million. We used historic data methods (using several European PBCRs reference rates), mortality-to-incidence ratios (M:I) comparison, and death certificate methods to calculate the proportion of unregistered cases (Lincoln-Petersen estimator and Ajiki formula).

Results

Incidence rate trends of different cancer types were stable over time (except one region - Leningrad oblast). A slight drop in incidence rates in older age groups for several sites in the Northwestern regions was observed compared to the reference from European countries. Comparing M:I ratios against five-year survival revealed systematic differences in Leningrad oblast and Vologda oblast. Assessment of completeness revealed low or unrealistic estimates in Leningrad oblast and completeness below 90% in St. Petersburg. In other regions, the completeness was above 90%. The national annual report between 2008-2017 did not include about 10% of the cases collected later in the registry database of St. Petersburg. This difference was below 3% for Arkhangelsk oblast, Murmansk oblast, Novgorod oblast, Vologda oblast and the Republic of Karelia.

Conclusions

Eight out of ten regional PBCRs in Northwest Russia collected data with an acceptable degree of completeness. Mostly populated St. Petersburg and Leningrad oblast did not reach such completeness. PBCR data from several regions in Northwest Russia are suitable for epidemiological research and monitoring cancer control activities.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jensen O, Storm H. Cancer registration: principles and methods. Purposes and uses of cancer registration. IARC Sci Publ. 1991;(95):7–21. Jensen O, Storm H. Cancer registration: principles and methods. Purposes and uses of cancer registration. IARC Sci Publ. 1991;(95):7–21.
2.
go back to reference Barchuk A, Belyaev A, Gretsova O, Tursun-Zade R, Moshina N, Znaor A. History and current status of cancer registration in Russia. Cancer Epidemiol. 2021;73:101963.CrossRefPubMed Barchuk A, Belyaev A, Gretsova O, Tursun-Zade R, Moshina N, Znaor A. History and current status of cancer registration in Russia. Cancer Epidemiol. 2021;73:101963.CrossRefPubMed
3.
go back to reference Bray F, Parkin DM. Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. Eur J Cancer. 2009;45(5):747–55. Bray F, Parkin DM. Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. Eur J Cancer. 2009;45(5):747–55.
4.
go back to reference Parkin DM, Bray F. Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness Eur J Cancer. 2009;45(5):756–64.CrossRefPubMed Parkin DM, Bray F. Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness Eur J Cancer. 2009;45(5):756–64.CrossRefPubMed
5.
go back to reference Barchuk A, Tursun-Zade R, Belayev A, Moore M, Komarov Y, Moshina N, et al. Comparability and validity of cancer registry data in the northwest of Russia. Acta Oncol. 2021;60(10):1264–71.CrossRefPubMed Barchuk A, Tursun-Zade R, Belayev A, Moore M, Komarov Y, Moshina N, et al. Comparability and validity of cancer registry data in the northwest of Russia. Acta Oncol. 2021;60(10):1264–71.CrossRefPubMed
6.
go back to reference Larsen IK, Småstuen M, Johannesen TB, Langmark F, Parkin DM, Bray F, et al. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer. 2009;45(7):1218–31.CrossRefPubMed Larsen IK, Småstuen M, Johannesen TB, Langmark F, Parkin DM, Bray F, et al. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer. 2009;45(7):1218–31.CrossRefPubMed
7.
go back to reference Leinonen MK, Miettinen J, Heikkinen S, Pitkäniemi J, Malila N. Quality measures of the population-based Finnish Cancer Registry indicate sound data quality for solid malignant tumours. Eur J Cancer. 2017;77:31–9.CrossRefPubMed Leinonen MK, Miettinen J, Heikkinen S, Pitkäniemi J, Malila N. Quality measures of the population-based Finnish Cancer Registry indicate sound data quality for solid malignant tumours. Eur J Cancer. 2017;77:31–9.CrossRefPubMed
8.
go back to reference Moore E, Silverman BG, Fishier Y, Ben-Adiva E, Davidov O, Dichtiar R, et al. An assessment of the completeness and timeliness of the Israel national cancer registry. Isr Med Assoc J. 2021;23(1):23–7.PubMed Moore E, Silverman BG, Fishier Y, Ben-Adiva E, Davidov O, Dichtiar R, et al. An assessment of the completeness and timeliness of the Israel national cancer registry. Isr Med Assoc J. 2021;23(1):23–7.PubMed
9.
go back to reference O’Brien K, Comber H, Sharp L. Completeness of case ascertainment at the Irish National Cancer Registry. Ir J Med Sci. 2014;183(2):219–24. O’Brien K, Comber H, Sharp L. Completeness of case ascertainment at the Irish National Cancer Registry. Ir J Med Sci. 2014;183(2):219–24.
10.
go back to reference Dimitrova N, Parkin DM. Data quality at the Bulgarian National Cancer Registry: an overview of comparability, completeness, validity and timeliness. Cancer Epidemiol. 2015;39(3):405–13.CrossRefPubMed Dimitrova N, Parkin DM. Data quality at the Bulgarian National Cancer Registry: an overview of comparability, completeness, validity and timeliness. Cancer Epidemiol. 2015;39(3):405–13.CrossRefPubMed
11.
go back to reference Lang K, Mägi M, Aareleid T. Study of completeness of registration at the Estonian cancer registry. Eur J Cancer Prev. 2003;12(2):153–6.CrossRefPubMed Lang K, Mägi M, Aareleid T. Study of completeness of registration at the Estonian cancer registry. Eur J Cancer Prev. 2003;12(2):153–6.CrossRefPubMed
12.
go back to reference Ryzhov A, Bray F, Ferlay J, Fedorenko Z, Goulak L, Gorokh Y, et al. Evaluation of data quality at the National Cancer Registry of Ukraine. Cancer Epidemiol. 2018;53:156–65.CrossRefPubMed Ryzhov A, Bray F, Ferlay J, Fedorenko Z, Goulak L, Gorokh Y, et al. Evaluation of data quality at the National Cancer Registry of Ukraine. Cancer Epidemiol. 2018;53:156–65.CrossRefPubMed
13.
go back to reference Wéber A, Mery L, Nagy P, Polgár C, Bray F, Kenessey I. Evaluation of data quality at the Hungarian National Cancer Registry, 2000–2019. Cancer Epidemiol. 2023;82:102306.CrossRefPubMed Wéber A, Mery L, Nagy P, Polgár C, Bray F, Kenessey I. Evaluation of data quality at the Hungarian National Cancer Registry, 2000–2019. Cancer Epidemiol. 2023;82:102306.CrossRefPubMed
14.
go back to reference Barchuk A, Bespalov A, Huhtala H, Chimed T, Laricheva I, Belyaev A, et al. Breast and cervical cancer incidence and mortality trends in Russia 1980–2013. Cancer Epidemiol. 2018;55:73–80.CrossRefPubMed Barchuk A, Bespalov A, Huhtala H, Chimed T, Laricheva I, Belyaev A, et al. Breast and cervical cancer incidence and mortality trends in Russia 1980–2013. Cancer Epidemiol. 2018;55:73–80.CrossRefPubMed
15.
go back to reference Barchuk A, Bespalov A, Huhtala H, Chimed T, Belyaev A, Moore M, et al. Productivity losses associated with premature mortality due to cancer in Russia: A population-wide study covering 2001–2030. Scand J Public Health. 2019;47(5):482–91.CrossRefPubMedPubMedCentral Barchuk A, Bespalov A, Huhtala H, Chimed T, Belyaev A, Moore M, et al. Productivity losses associated with premature mortality due to cancer in Russia: A population-wide study covering 2001–2030. Scand J Public Health. 2019;47(5):482–91.CrossRefPubMedPubMedCentral
16.
go back to reference Ferlay J, Burkhard C, Whelan S, Parkin D. Check and conversion programs check and conversion programs. IARC; 2005. Ferlay J, Burkhard C, Whelan S, Parkin D. Check and conversion programs check and conversion programs. IARC; 2005.
19.
go back to reference Bray F, Colombet M, Mery L, Piñeros M, Znaor A, Zanetti R, et al. Cancer incidence in five continents, vol. 11. Lyon: International Agency for Research on Cancer; 2017. Bray F, Colombet M, Mery L, Piñeros M, Znaor A, Zanetti R, et al. Cancer incidence in five continents, vol. 11. Lyon: International Agency for Research on Cancer; 2017.
20.
go back to reference Ervik M, Lam F, Laversanne M, Ferlay J, Bray F. Global Cancer Observatory: Cancer over time. Lyon: International Agency for Research on Cancer; 2021. https://gco.iarc.fr/overtime. Retrieved January 19, 2022. Ervik M, Lam F, Laversanne M, Ferlay J, Bray F. Global Cancer Observatory: Cancer over time. Lyon: International Agency for Research on Cancer; 2021. https://​gco.​iarc.​fr/​overtime. Retrieved January 19, 2022.
21.
go back to reference Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint Å, et al. NORDCAN-a Nordic tool for cancer information, planning, quality control and research. Acta Oncol. 2010;49(5):725–36.CrossRefPubMed Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint Å, et al. NORDCAN-a Nordic tool for cancer information, planning, quality control and research. Acta Oncol. 2010;49(5):725–36.CrossRefPubMed
22.
go back to reference Danckert B, Ferlay J, Engholm G, Hansen H, Johannesen T, Khan S, et al. NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 8.2 (26.03.2019). Association of the Nordic Cancer Registries; 2019. http://www.ancr.nu. Retrieved September 20, 2019. Danckert B, Ferlay J, Engholm G, Hansen H, Johannesen T, Khan S, et al. NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 8.2 (26.03.2019). Association of the Nordic Cancer Registries; 2019. http://​www.​ancr.​nu. Retrieved September 20, 2019.
23.
go back to reference Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. Methodological note; 1959. Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. Methodological note; 1959.
24.
go back to reference Perme MP, Pavlic K. Nonparametric relative survival analysis with the R package relsurv. J Stat Softw. 2018;87:1–27.CrossRef Perme MP, Pavlic K. Nonparametric relative survival analysis with the R package relsurv. J Stat Softw. 2018;87:1–27.CrossRef
25.
go back to reference Asadzadeh Vostakolaei F, Karim-Kos HE, Janssen-Heijnen ML, Visser O, Verbeek AL, Kiemeney LA. The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival. Eur J Public Health. 2011;21(5):573–7.CrossRefPubMed Asadzadeh Vostakolaei F, Karim-Kos HE, Janssen-Heijnen ML, Visser O, Verbeek AL, Kiemeney LA. The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival. Eur J Public Health. 2011;21(5):573–7.CrossRefPubMed
26.
go back to reference Tilling K, Sterne JA. Capture-recapture models including covariate effects. Am J Epidemiol. 1999;149(4):392–400.CrossRefPubMed Tilling K, Sterne JA. Capture-recapture models including covariate effects. Am J Epidemiol. 1999;149(4):392–400.CrossRefPubMed
27.
go back to reference Ajiki W, Tsukuma H, Oshima A. Index for evaluating completeness of registration in population-based cancer registries and estimation of registration rate at the Osaka Cancer Registry between 1966 and 1992 using this index. [Nihon Koshu Eisei Zasshi] Jpn J Public Health. 1998;45(10):1011–7. Ajiki W, Tsukuma H, Oshima A. Index for evaluating completeness of registration in population-based cancer registries and estimation of registration rate at the Osaka Cancer Registry between 1966 and 1992 using this index. [Nihon Koshu Eisei Zasshi] Jpn J Public Health. 1998;45(10):1011–7.
28.
go back to reference van der Willik KD, Ruiter R, van Rooij FJ, Verkroost-van Heemst J, Hogewoning SJ, Timmermans KC, et al. Ascertainment of cancer in longitudinal research: The concordance between the Rotterdam Study and the Netherlands Cancer Registry. Int J Cancer. 2020;147(3):633–40.CrossRefPubMed van der Willik KD, Ruiter R, van Rooij FJ, Verkroost-van Heemst J, Hogewoning SJ, Timmermans KC, et al. Ascertainment of cancer in longitudinal research: The concordance between the Rotterdam Study and the Netherlands Cancer Registry. Int J Cancer. 2020;147(3):633–40.CrossRefPubMed
29.
go back to reference Hamaker ME, Hamelinck VC, van Munster BC, Bastiaannet E, Smorenburg CH, Achterberg WP, et al. Nonreferral of nursing home patients with suspected breast cancer. J Am Med Dir Assoc. 2012;13(5):464–9.CrossRefPubMed Hamaker ME, Hamelinck VC, van Munster BC, Bastiaannet E, Smorenburg CH, Achterberg WP, et al. Nonreferral of nursing home patients with suspected breast cancer. J Am Med Dir Assoc. 2012;13(5):464–9.CrossRefPubMed
30.
go back to reference Anttila A, Sarkeala T, Hakulinen T, Heinävaara S. Impacts of the Finnish service screening programme on breast cancer rates. BMC Public Health. 2008;8(1):1–10.CrossRef Anttila A, Sarkeala T, Hakulinen T, Heinävaara S. Impacts of the Finnish service screening programme on breast cancer rates. BMC Public Health. 2008;8(1):1–10.CrossRef
31.
go back to reference Fung JWM, Lim SBL, Zheng H, Ho WYT, Lee BG, Chow KY, et al. Data quality at the Singapore Cancer Registry: An overview of comparability, completeness, validity and timeliness. Cancer Epidemiol. 2016;43:76–86.CrossRefPubMed Fung JWM, Lim SBL, Zheng H, Ho WYT, Lee BG, Chow KY, et al. Data quality at the Singapore Cancer Registry: An overview of comparability, completeness, validity and timeliness. Cancer Epidemiol. 2016;43:76–86.CrossRefPubMed
32.
go back to reference Sigurdardottir LG, Jonasson JG, Stefansdottir S, Jonsdottir A, Olafsdottir GH, Olafsdottir EJ, et al. Data quality at the Icelandic Cancer Registry: comparability, validity, timeliness and completeness. Acta Oncol. 2012;51(7):880–9.CrossRefPubMed Sigurdardottir LG, Jonasson JG, Stefansdottir S, Jonsdottir A, Olafsdottir GH, Olafsdottir EJ, et al. Data quality at the Icelandic Cancer Registry: comparability, validity, timeliness and completeness. Acta Oncol. 2012;51(7):880–9.CrossRefPubMed
Metadata
Title
Completeness of regional cancer registry data in Northwest Russia 2008-2017
Authors
Anton Barchuk
Rustam Tursun-zade
Ekaterina Nazarova
Yuri Komarov
Ekaterina Tyurina
Yulia Tumanova
Alexey Belyaev
Ariana Znaor
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2023
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-11492-z

Other articles of this Issue 1/2023

BMC Cancer 1/2023 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine